Advancing Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator, a Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations ...
VY1706 and NBIB-‘233 completed IND-enabling GLP toxicology; clinical entry expected H2 2026 -- Multiple presentations at ...
AB-1009, an adeno-associated virus (AAV) investigational gene therapy, is being evaluated for the treatment of late-onset Pompe disease (LOPD) in the PROGRESS-GT LOPD trial AskBio initiated ...
Oral presentation at ASGCT showcases breakthrough technology enabling precise in vivo genome editing in the CNS using a ...
Stephen Hawkings quote, “The past, like the future, is indefinite and exists only as a spectrum of possibilities,” challenges ...
Hosted on MSN
The 2026 Cash Flow Gap: How to Time SSDI, Schwab Withdrawals, and Section 125 Benefits Without Losing Money
In 2026, the average SSDI application takes 3 to 6 months for an initial decision, with a mandatory five-month waiting period before payments begin—creating a potential financial cliff for those ...
VY1706 and NBIB-'233 completed IND-enabling GLP toxicology; clinical entry expected H2 2026 - - Multiple presentations at ASGCT 2026, including late breaker on VY1706 3-month GLP tox data - - Ended ...
M.A.C.B.E.T.H., opening at Art Farm at Serenbe on May 8, is a sitcom-inspired retelling of the tragic Shakespearean tale.
Lowell's First Look on MSN
Hospice care eligibility and timing: It’s more than you may think
Each month, we bring you an article from Emmanuel Hospice, which has been recognized as one of the Best and Brightest ...
The tax changes announced in this week’s federal budget may be the most significant for years, but BT’s technical expert ...
Microvast Holdings, Inc. (NASDAQ:MVST) ("Microvast" or the "Company"), a global leader in advanced battery technologies, announced today its unaudited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results